Hua Medicine Announces 2019 Annual Results
- Written by ACN Newswire - Press Releases
SHANGHAI, Mar 16, 2020 - (ACN Newswire) - Hua Medicine (the "Company", Stock Code on The Stock Exchange of Hong Kong Limited: 2552.HK), a global innovative drug research and development company focused on novel therapies for the treatment of diabetes, today announces the audited consolidated results of the Company and its subsidiaries for the
Read more //?#